The Avellino SARS-CoV-2/COVID-19 Test (AvellinoCoV2) is a non-invasive, swab based test used to detect the
SARS-CoV-2 virus, a strong indicator of the patient having the COVID-19 disease. A positive result generally
indicates an active infection, while a negative result should not be used as the sole basis for treatment or
other patient management decisions.
All results, whether positive or negative, must be combined with clinical observations, patient history, and
epidemiological information for a proper medical diagnosis. AvellinoCoV2 was developed by Avellino Lab USA,
Inc., in its CLIA-qualified lab and is authorized by the FDA under the Emergency Use Authorization.
Health care provider orders and receives the
AvellinoCoV2 test kit.
Health care provider collects swab samples from the
patient’s nose and mouth.
Health care provider ships the patient's sample to
Avellino conducts lab testing.
Avellino prepares the patient report.
Sample Negative Patient
Sample Positive Patient
Avellino sends the results to your health care provider.
Find out how Avellino partnered with other companies to create a comprehensive corporate testing solution for returning to work. Visit lifesite.co for more information.